• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma.

作者信息

Pisapia David J, Magge Rajiv, Ramakrishna Rohan

机构信息

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, United States.

Department of Neurology, Weill Cornell Medical College, New York, NY, United States.

出版信息

Front Neurol. 2017 Dec 19;8:707. doi: 10.3389/fneur.2017.00707. eCollection 2017.

DOI:10.3389/fneur.2017.00707
PMID:29312129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5742147/
Abstract
摘要

相似文献

1
Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma.改进的病理诊断——预测胶质母细胞瘤的未来
Front Neurol. 2017 Dec 19;8:707. doi: 10.3389/fneur.2017.00707. eCollection 2017.
2
IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.异柠檬酸脱氢酶（IDH）突变和O6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化与接受同步和辅助替莫唑胺化疗放疗的多形性胶质母细胞瘤患者的假性进展及预后改善相关。
Clin Neurol Neurosurg. 2016 Dec;151:31-36. doi: 10.1016/j.clineuro.2016.10.004. Epub 2016 Oct 12.
3
Impact of Multifocality and Molecular Markers on Survival of Glioblastoma.多灶性和分子标志物对胶质母细胞瘤生存的影响
World Neurosurg. 2019 Feb;122:e461-e466. doi: 10.1016/j.wneu.2018.10.075. Epub 2018 Oct 19.
4
Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification.胶质母细胞瘤中的肿瘤内 DNA 甲基化异质性：对基于 DNA 甲基化的分类的影响。
Neuro Oncol. 2019 May 6;21(5):616-627. doi: 10.1093/neuonc/noz011.
5
Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.动脉自旋标记灌注加权成像有助于预测胶质母细胞瘤的分子生物标志物和生存。
Eur Radiol. 2020 Feb;30(2):1202-1211. doi: 10.1007/s00330-019-06379-2. Epub 2019 Aug 29.
6
Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.基于13基因特征的联合治疗敏感性指数预测IDH野生型和MGMT启动子未甲基化胶质母细胞瘤患者的预后。
J Cancer. 2019 Aug 29;10(22):5536-5548. doi: 10.7150/jca.30614. eCollection 2019.
7
O-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma.O-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化和异柠檬酸脱氢酶突变作为沙特胶质母细胞瘤患者队列中的预后因素。
Ann Saudi Med. 2019 Nov-Dec;39(6):410-416. doi: 10.5144/0256-4947.2019.410. Epub 2019 Dec 5.
8
Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.基于分子标志物的胶质母细胞瘤手术：新诊断的 IDH-1 野生型胶质母细胞瘤中切除和 MGMT 启动子甲基化的影响。
Neurosurgery. 2019 Jan 1;84(1):190-197. doi: 10.1093/neuros/nyy049.
9
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation.436例新诊断的异柠檬酸脱氢酶（IDH）野生型胶质母细胞瘤伴与不伴O6-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化的地形图绘制
Front Oncol. 2020 May 12;10:596. doi: 10.3389/fonc.2020.00596. eCollection 2020.
10
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.通过对 2016 年 WHO 弥漫性胶质瘤分类进行以下四项指标的细化：EGFR 扩增、TERT 突变、PTEN 缺失和 MGMT 甲基化，获得的临床见解。
BMC Cancer. 2019 Oct 17;19(1):968. doi: 10.1186/s12885-019-6177-0.

引用本文的文献

1
Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers.肌红蛋白在正常脑组织和癌组织中的表达：与缺氧标志物的相关性
Front Oncol. 2021 Apr 30;11:590771. doi: 10.3389/fonc.2021.590771. eCollection 2021.
2
Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions.管状脑肿瘤活检提高了皮质下病变的诊断产量。
J Neurooncol. 2019 Jan;141(1):121-129. doi: 10.1007/s11060-018-03014-w. Epub 2018 Nov 16.

本文引用的文献

1
Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma.胶质母细胞瘤中免疫检查点阻断的临床试验研究
Curr Treat Options Oncol. 2017 Aug;18(8):51. doi: 10.1007/s11864-017-0492-y.
2
Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma.检查点抑制剂的当前进展：来自非中枢神经系统癌症的经验教训及胶质母细胞瘤的治疗潜力
Front Oncol. 2017 Jul 6;7:141. doi: 10.3389/fonc.2017.00141. eCollection 2017.
3
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.在经标准放化疗治疗的异柠檬酸脱氢酶1（IDH1）野生型原发性胶质母细胞瘤中，人端粒酶逆转录酶（TERT）启动子突变可使甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子甲基化带来生存优势。
Neuro Oncol. 2017 Mar 1;19(3):394-404. doi: 10.1093/neuonc/now189.
4
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.TERT 启动子突变与 MGMT 甲基化状态相结合可预测新诊断的胶质母细胞瘤中有临床意义的亚组。
Acta Neuropathol Commun. 2016 Aug 8;4(1):79. doi: 10.1186/s40478-016-0351-2.
5
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
6
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.免疫检查点抑制治疗胚系双等位基因错配修复缺陷所致超突变胶质母细胞瘤多形性。
J Clin Oncol. 2016 Jul 1;34(19):2206-11. doi: 10.1200/JCO.2016.66.6552. Epub 2016 Mar 21.
7
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.新的脑肿瘤实体源于中枢神经系统原始神经外胚层肿瘤的分子分类。
Cell. 2016 Feb 25;164(5):1060-1072. doi: 10.1016/j.cell.2016.01.015.
8
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.分子分析揭示弥漫性胶质瘤的生物学离散亚群和进展途径。
Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.
9
Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.告别胶质母细胞瘤伴少突胶质细胞瘤成分：具有少突胶质细胞瘤成分的胶质母细胞瘤的基因组和转录组分析揭示了不同的分子亚群。
Acta Neuropathol Commun. 2016 Jan 13;4:4. doi: 10.1186/s40478-015-0270-7.
10
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.靶向新一代测序panel（GlioSeq）可对中枢神经系统肿瘤进行全面的基因分析。
Neuro Oncol. 2016 Mar;18(3):379-87. doi: 10.1093/neuonc/nov289. Epub 2015 Dec 17.